Shares in BioScrip (BIOS) are higher today as shares bounce from a soft quarter a few months back. Shares are higher today with good volume as investors see value for these shares below it’s breakdown low of $1.15 after the last earnings call.
See chart below.
BioScrip, Inc. provides home infusion services in the United States. The company engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. It is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. BioScrip, Inc. offers its services at patient?s homes, outpatient clinics, nursing facilities, physician?s offices, and ambulatory infusion centers. The company markets and sells its products and services through sales and marketing representatives, payor relationships, and other government programs. BioScrip, Inc. was founded in 1993 and is based in Denver, Colorado.